Concepedia

Publication | Open Access

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy

DOIFull Paper Access

42

Citations

13

References

2020

Year

Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson, David L. DeMets, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Anna Maria Langkilde, Felipe A. Martínez, Marc S. Sabatine,
Diabetes Care

Abstract

In DAPA-HF, dapagliflozin improved outcomes irrespective of use or no use of GLT or by GLT type used in patients with type 2 diabetes and HFrEF.

References

YearCitations

Page 1